Dr Reddy's joins other Indian firms to make Remdesivir under Gilead licence

DRL to receive technology transfer from Gilead and would need to scale up manufacturing and obtain regulatory approvals from 127 countries for marketing the drug

from Companies https://ift.tt/3fjVg3h
via IFTTT